Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E.M. Miller is active.

Publication


Featured researches published by E.M. Miller.


Gynecologic Oncology | 2018

Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors

Amerigo Rossi; Laena Frechette; Devin Miller; E.M. Miller; Ciaran P. Friel; Anne Van Arsdale; Juan Lin; Viswanathan Shankar; D.Y.S. Kuo; N.S. Nevadunsky

OBJECTIVE Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70% obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. METHODS Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. RESULTS Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m-2. Self-identified race/ethnicity was 36% Hispanic, 36% non-Hispanic white, 16% non-Hispanic black and 12% Asian. Participants wore the Fitbits a median of 93% of possible days. Median daily Fitbit step count was 5325 (IQR: 3761-8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. CONCLUSIONS The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.


Journal of Clinical Oncology | 2018

Association of diabetes mellitus with an increased risk of recurrence and disease progression in women with ovarian granulosa cell tumors.

Joan Tymon-Rosario; E.M. Miller; Gregory M. Gressel; Nicole Suzanne Nevadunsky


Journal of Clinical Oncology | 2018

Association of unplanned hospitalizations after chemotherapy with disease specific survival in a racially ethnically diverse population of women with epithelial ovarian cancer.

Shayan M Dioun; E.M. Miller; Jennifer Jorgensen; Joan Tymon-Rosario; Xianhong Xie; Xiaonan Xue; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky


Gynecologic Oncology | 2018

Acceptability and feasibility of wearable fitness technology for endometrial cancer survivors

L. Frechette; D.T. Miller; Amerigo Rossi; E.M. Miller; A.R. Van Arsdale; Shankar Viswanathan; Nicole Suzanne Nevadunsky


Journal of Clinical Oncology | 2017

Survival disparity and racial differences in the use of neoadjuvant chemotherapy (NAC) compared with primary debulking surgery (PDS) in women with ovarian cancer.

E.M. Miller; Joan Tymon-Rosario; Xianhong Xie; Harriet Olivia Smith; Gary L. Goldberg; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky


Journal of Clinical Oncology | 2017

A retrospective evaluation of unplanned hospital admission rates for women with ovarian cancer.

S.M. Dioun; E.M. Miller; Joan Tymon-Rosario; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky


Journal of Clinical Oncology | 2017

Acceptability of FitBit activity trackers for socioculturally diverse endometrial cancer survivors: A pilot study.

E.M. Miller; Amerigo Rossi; David Samuel; Carolina Ramirez; Shankar Viswanathan; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky


Journal of Clinical Oncology | 2017

Assessment of a custom designed next generation DNA sequencing gene panel to profile endometrial cancers.

E.M. Miller; Nicole Patterson; Rouzan G. Karabakhtsian; Michal Bejerano-Sagie; Nivi Ravi; Alexander Y. Maslov; Wilber Quispe-Tintaya; Tao Wang; Juan Lin; Harriet Olivia Smith; Dennis Yi-Shin Kuo; Gary L. Goldberg; Cristina Montagna


Gynecologic Oncology | 2017

Survival impact of pelvic and para-aortic lymph node sampling in patients with completely resected stage I-IV uterine serous carcinoma (USC)

N.M. Acosta; E.M. Miller; Shankar Viswanathan; V. Hastings; Gary L. Goldberg; Dennis Yi-Shin Kuo; Marina Frimer


Gynecologic Oncology | 2017

Adjuvant pelvic radiation sandwiched between paclitaxel/carboplatin chemotherapy in women with completely resected uterine serous carcinoma (USC): A prospective phase II trial update

E.M. Miller; Shankar Viswanathan; S. Li; Keyur J. Mehta; Harriet O. Smith; D. Smotkin; Dennis Yi-Shin Kuo; Gary L. Goldberg; Mark H. Einstein; Marina Frimer

Collaboration


Dive into the E.M. Miller's collaboration.

Top Co-Authors

Avatar

Dennis Yi-Shin Kuo

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Gary L. Goldberg

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shankar Viswanathan

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D.T. Miller

Montefiore Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xianhong Xie

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

A.P. Novetsky

Albert Einstein College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge